Literature DB >> 34282767

Syndecan-4 in Tumor Cell Motility.

Aniko Keller-Pinter1, Szuzina Gyulai-Nagy1, Daniel Becsky1, Laszlo Dux1, Laszlo Rovo2.   

Abstract

Syndecan-4 (SDC4) is a ubiquitously expressed, transmembrane proteoglycan bearing heparan sulfate chains. SDC4 is involved in numerous inside-out and outside-in signaling processes, such as binding and sequestration of growth factors and extracellular matrix components, regulation of the activity of the small GTPase Rac1, protein kinase C-alpha, the level of intracellular calcium, or the phosphorylation of focal adhesion kinase. The ability of this proteoglycan to link the extracellular matrix and actin cytoskeleton enables SDC4 to contribute to biological functions like cell adhesion and migration, cell proliferation, cytokinesis, cellular polarity, or mechanotransduction. The multiple roles of SDC4 in tumor pathogenesis and progression has already been demonstrated; therefore, the expression and signaling of SDC4 was investigated in several tumor types. SDC4 influences tumor progression by regulating cell proliferation as well as cell migration by affecting cell-matrix adhesion and several signaling pathways. Here, we summarize the general role of SDC4 in cell migration and tumor cell motility.

Entities:  

Keywords:  EMT; actin; calcium; cancer; cell polarity; centrosome; extracellular matrix; metastasis; migration; proteoglycan; syndecan-4

Year:  2021        PMID: 34282767     DOI: 10.3390/cancers13133322

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  6 in total

1.  Eltrombopag binds SDC4 directly and enhances MAPK signaling and macropinocytosis in cancer cells.

Authors:  Can Cui; Yuting Pan; Chengqian Zhang; Darong Zhu; Ying Xuan; Piliang Hao; Xisong Ke; Xianglian Zhou; Yi Qu
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

Review 2.  Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling.

Authors:  Nazareth Milagros Carigga Gutierrez; Núria Pujol-Solé; Qendresa Arifi; Jean-Luc Coll; Tristan le Clainche; Mans Broekgaarden
Journal:  Cancer Metastasis Rev       Date:  2022-09-26       Impact factor: 9.237

3.  Keloid Biomarkers and Their Correlation With Immune Infiltration.

Authors:  Xufeng Yin; Wenbo Bu; Fang Fang; Kehui Ren; Bingrong Zhou
Journal:  Front Genet       Date:  2022-06-02       Impact factor: 4.772

4.  Syndecan-4 affects myogenesis via Rac1-mediated actin remodeling and exhibits copy-number amplification and increased expression in human rhabdomyosarcoma tumors.

Authors:  Kitti Szabo; Daniel Varga; Attila Gergely Vegh; Ning Liu; Xue Xiao; Lin Xu; Laszlo Dux; Miklos Erdelyi; Laszlo Rovo; Aniko Keller-Pinter
Journal:  Cell Mol Life Sci       Date:  2022-02-07       Impact factor: 9.261

5.  Comprehensive Analysis and Reinforcement Learning of Hypoxic Genes Based on Four Machine Learning Algorithms for Estimating the Immune Landscape, Clinical Outcomes, and Therapeutic Implications in Patients With Lung Adenocarcinoma.

Authors:  Zhaoyang Sun; Yu Zeng; Ting Yuan; Xiaoying Chen; Hua Wang; Xiaowei Ma
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

6.  High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma.

Authors:  Yufei Zhu; Dijie Zheng; Linhan Lei; Kun Cai; Huahua Xie; Jian Zheng; Chao Yu
Journal:  BMC Cancer       Date:  2022-10-05       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.